ArticleEuropean heart journal2019

Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.